Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Identifieur interne : 003534 ( Main/Exploration ); précédent : 003533; suivant : 003535Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Auteurs : Sally F. Barrington ; N. George Mikhaeel ; Lale Kostakoglu ; Michel Meignan ; Martin Hutchings ; Stefan P. Müeller ; Lawrence H. Schwartz ; Emanuele Zucca ; Richard I. Fisher ; Judith Trotman ; Otto S. Hoekstra ; Rodney J. Hicks ; Michael J. O'Doherty ; Roland Hustinx ; Alberto Biggi ; Bruce D. ChesonSource :
- Journal of Clinical Oncology [ 0732-183X ] ; 2014.
Abstract
Recent advances in imaging, use of prognostic indices, and molecular profiling techniques have the potential to improve disease characterization and outcomes in lymphoma. International trials are under way to test image-based response–adapted treatment guided by early interim positron emission tomography (PET) –computed tomography (CT). Progress in imaging is influencing trial design and affecting clinical practice. In particular, a five-point scale to grade response using PET-CT, which can be adapted to suit requirements for early- and late-response assessment with good interobserver agreement, is becoming widely used both in practice- and response-adapted trials. A workshop held at the 11th International Conference on Malignant Lymphomas (ICML) in 2011 concluded that revision to current staging and response criteria was timely.
An imaging working group composed of representatives from major international cooperative groups was asked to review the literature, share knowledge about research in progress, and identify key areas for research pertaining to imaging and lymphoma.
A working paper was circulated for comment and presented at the Fourth International Workshop on PET in Lymphoma in Menton, France, and the 12th ICML in Lugano, Switzerland, to update the International Harmonisation Project guidance regarding PET. Recommendations were made to optimize the use of PET-CT in staging and response assessment of lymphoma, including qualitative and quantitative methods.
This article comprises the consensus reached to update guidance on the use of PET-CT for staging and response assessment for [18F]fluorodeoxyglucose-avid lymphomas in clinical practice and late-phase trials.
Url:
DOI: 10.1200/JCO.2013.53.5229
PubMed: 25113771
PubMed Central: 5015423
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 001958
- to stream Pmc, to step Curation: 001817
- to stream Pmc, to step Checkpoint: 001359
- to stream Ncbi, to step Merge: 001D10
- to stream Ncbi, to step Curation: 001D10
- to stream Ncbi, to step Checkpoint: 001D10
- to stream Main, to step Merge: 003550
- to stream Main, to step Curation: 003534
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group</title><author><name sortKey="Barrington, Sally F" sort="Barrington, Sally F" uniqKey="Barrington S" first="Sally F." last="Barrington">Sally F. Barrington</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Mikhaeel, N George" sort="Mikhaeel, N George" uniqKey="Mikhaeel N" first="N. George" last="Mikhaeel">N. George Mikhaeel</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Kostakoglu, Lale" sort="Kostakoglu, Lale" uniqKey="Kostakoglu L" first="Lale" last="Kostakoglu">Lale Kostakoglu</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Meignan, Michel" sort="Meignan, Michel" uniqKey="Meignan M" first="Michel" last="Meignan">Michel Meignan</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Hutchings, Martin" sort="Hutchings, Martin" uniqKey="Hutchings M" first="Martin" last="Hutchings">Martin Hutchings</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Mueller, Stefan P" sort="Mueller, Stefan P" uniqKey="Mueller S" first="Stefan P." last="Müeller">Stefan P. Müeller</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Schwartz, Lawrence H" sort="Schwartz, Lawrence H" uniqKey="Schwartz L" first="Lawrence H." last="Schwartz">Lawrence H. Schwartz</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Zucca, Emanuele" sort="Zucca, Emanuele" uniqKey="Zucca E" first="Emanuele" last="Zucca">Emanuele Zucca</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Fisher, Richard I" sort="Fisher, Richard I" uniqKey="Fisher R" first="Richard I." last="Fisher">Richard I. Fisher</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Trotman, Judith" sort="Trotman, Judith" uniqKey="Trotman J" first="Judith" last="Trotman">Judith Trotman</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Hoekstra, Otto S" sort="Hoekstra, Otto S" uniqKey="Hoekstra O" first="Otto S." last="Hoekstra">Otto S. Hoekstra</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Hicks, Rodney J" sort="Hicks, Rodney J" uniqKey="Hicks R" first="Rodney J." last="Hicks">Rodney J. Hicks</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="O Doherty, Michael J" sort="O Doherty, Michael J" uniqKey="O Doherty M" first="Michael J." last="O'Doherty">Michael J. O'Doherty</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Hustinx, Roland" sort="Hustinx, Roland" uniqKey="Hustinx R" first="Roland" last="Hustinx">Roland Hustinx</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Biggi, Alberto" sort="Biggi, Alberto" uniqKey="Biggi A" first="Alberto" last="Biggi">Alberto Biggi</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Cheson, Bruce D" sort="Cheson, Bruce D" uniqKey="Cheson B" first="Bruce D." last="Cheson">Bruce D. Cheson</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">25113771</idno><idno type="pmc">5015423</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015423</idno><idno type="RBID">PMC:5015423</idno><idno type="doi">10.1200/JCO.2013.53.5229</idno><date when="2014">2014</date><idno type="wicri:Area/Pmc/Corpus">001958</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001958</idno><idno type="wicri:Area/Pmc/Curation">001817</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001817</idno><idno type="wicri:Area/Pmc/Checkpoint">001359</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001359</idno><idno type="wicri:Area/Ncbi/Merge">001D10</idno><idno type="wicri:Area/Ncbi/Curation">001D10</idno><idno type="wicri:Area/Ncbi/Checkpoint">001D10</idno><idno type="wicri:doubleKey">0732-183X:2014:Barrington S:role:of:imaging</idno><idno type="wicri:Area/Main/Merge">003550</idno><idno type="wicri:Area/Main/Curation">003534</idno><idno type="wicri:Area/Main/Exploration">003534</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group</title><author><name sortKey="Barrington, Sally F" sort="Barrington, Sally F" uniqKey="Barrington S" first="Sally F." last="Barrington">Sally F. Barrington</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Mikhaeel, N George" sort="Mikhaeel, N George" uniqKey="Mikhaeel N" first="N. George" last="Mikhaeel">N. George Mikhaeel</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Kostakoglu, Lale" sort="Kostakoglu, Lale" uniqKey="Kostakoglu L" first="Lale" last="Kostakoglu">Lale Kostakoglu</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Meignan, Michel" sort="Meignan, Michel" uniqKey="Meignan M" first="Michel" last="Meignan">Michel Meignan</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Hutchings, Martin" sort="Hutchings, Martin" uniqKey="Hutchings M" first="Martin" last="Hutchings">Martin Hutchings</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Mueller, Stefan P" sort="Mueller, Stefan P" uniqKey="Mueller S" first="Stefan P." last="Müeller">Stefan P. Müeller</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Schwartz, Lawrence H" sort="Schwartz, Lawrence H" uniqKey="Schwartz L" first="Lawrence H." last="Schwartz">Lawrence H. Schwartz</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Zucca, Emanuele" sort="Zucca, Emanuele" uniqKey="Zucca E" first="Emanuele" last="Zucca">Emanuele Zucca</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Fisher, Richard I" sort="Fisher, Richard I" uniqKey="Fisher R" first="Richard I." last="Fisher">Richard I. Fisher</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Trotman, Judith" sort="Trotman, Judith" uniqKey="Trotman J" first="Judith" last="Trotman">Judith Trotman</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Hoekstra, Otto S" sort="Hoekstra, Otto S" uniqKey="Hoekstra O" first="Otto S." last="Hoekstra">Otto S. Hoekstra</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Hicks, Rodney J" sort="Hicks, Rodney J" uniqKey="Hicks R" first="Rodney J." last="Hicks">Rodney J. Hicks</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="O Doherty, Michael J" sort="O Doherty, Michael J" uniqKey="O Doherty M" first="Michael J." last="O'Doherty">Michael J. O'Doherty</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Hustinx, Roland" sort="Hustinx, Roland" uniqKey="Hustinx R" first="Roland" last="Hustinx">Roland Hustinx</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Biggi, Alberto" sort="Biggi, Alberto" uniqKey="Biggi A" first="Alberto" last="Biggi">Alberto Biggi</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author><author><name sortKey="Cheson, Bruce D" sort="Cheson, Bruce D" uniqKey="Cheson B" first="Bruce D." last="Cheson">Bruce D. Cheson</name><affiliation><nlm:aff id="aff1">Sally F. Barrington and Michael J. O'Doherty, King's College London; N. George Mikhaeel, Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom; Lale Kostakoglu, Mount Sinai Medical Center; Lawrence H. Schwartz, Columbia University Medical Center, New York, NY; Michel Meignan, Centre Universitaire Hospitalier Henri Mondor, Paris, France; Martin Hutchings, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Stefan P. Müeller, Klinik für Nuklearmedizin, Universitätsklinikum Essen, Germany; Emanuele Zucca, Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Richard I. Fisher, Fox Chase Cancer Center, Philadelphia, PA; Judith Trotman, Concord Hospital and University of Sydney, Sydney, New South Wales; Rodney J. Hicks, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria, Australia; Otto S. Hoekstra, Vrije Universiteit Medical Center, Amsterdam, the Netherlands; Roland Hustinx, University of Liège, Liège, Belgium; Alberto Biggi, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy; and Bruce D. Cheson, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC.</nlm:aff><wicri:noCountry code="subfield">DC.</wicri:noCountry></affiliation></author></analytic><series><title level="j">Journal of Clinical Oncology</title><idno type="ISSN">0732-183X</idno><idno type="eISSN">1527-7755</idno><imprint><date when="2014">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Purpose</title><p>Recent advances in imaging, use of prognostic indices, and molecular profiling techniques have the potential to improve disease characterization and outcomes in lymphoma. International trials are under way to test image-based response–adapted treatment guided by early interim positron emission tomography (PET) –computed tomography (CT). Progress in imaging is influencing trial design and affecting clinical practice. In particular, a five-point scale to grade response using PET-CT, which can be adapted to suit requirements for early- and late-response assessment with good interobserver agreement, is becoming widely used both in practice- and response-adapted trials. A workshop held at the 11th International Conference on Malignant Lymphomas (ICML) in 2011 concluded that revision to current staging and response criteria was timely.</p></sec><sec><title>Methods</title><p>An imaging working group composed of representatives from major international cooperative groups was asked to review the literature, share knowledge about research in progress, and identify key areas for research pertaining to imaging and lymphoma.</p></sec><sec><title>Results</title><p>A working paper was circulated for comment and presented at the Fourth International Workshop on PET in Lymphoma in Menton, France, and the 12th ICML in Lugano, Switzerland, to update the International Harmonisation Project guidance regarding PET. Recommendations were made to optimize the use of PET-CT in staging and response assessment of lymphoma, including qualitative and quantitative methods.</p></sec><sec><title>Conclusion</title><p>This article comprises the consensus reached to update guidance on the use of PET-CT for staging and response assessment for [<sup>18</sup>F]fluorodeoxyglucose-avid lymphomas in clinical practice and late-phase trials.</p></sec></div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Barrington, Sally F" sort="Barrington, Sally F" uniqKey="Barrington S" first="Sally F." last="Barrington">Sally F. Barrington</name><name sortKey="Biggi, Alberto" sort="Biggi, Alberto" uniqKey="Biggi A" first="Alberto" last="Biggi">Alberto Biggi</name><name sortKey="Cheson, Bruce D" sort="Cheson, Bruce D" uniqKey="Cheson B" first="Bruce D." last="Cheson">Bruce D. Cheson</name><name sortKey="Fisher, Richard I" sort="Fisher, Richard I" uniqKey="Fisher R" first="Richard I." last="Fisher">Richard I. Fisher</name><name sortKey="Hicks, Rodney J" sort="Hicks, Rodney J" uniqKey="Hicks R" first="Rodney J." last="Hicks">Rodney J. Hicks</name><name sortKey="Hoekstra, Otto S" sort="Hoekstra, Otto S" uniqKey="Hoekstra O" first="Otto S." last="Hoekstra">Otto S. Hoekstra</name><name sortKey="Hustinx, Roland" sort="Hustinx, Roland" uniqKey="Hustinx R" first="Roland" last="Hustinx">Roland Hustinx</name><name sortKey="Hutchings, Martin" sort="Hutchings, Martin" uniqKey="Hutchings M" first="Martin" last="Hutchings">Martin Hutchings</name><name sortKey="Kostakoglu, Lale" sort="Kostakoglu, Lale" uniqKey="Kostakoglu L" first="Lale" last="Kostakoglu">Lale Kostakoglu</name><name sortKey="Meignan, Michel" sort="Meignan, Michel" uniqKey="Meignan M" first="Michel" last="Meignan">Michel Meignan</name><name sortKey="Mikhaeel, N George" sort="Mikhaeel, N George" uniqKey="Mikhaeel N" first="N. George" last="Mikhaeel">N. George Mikhaeel</name><name sortKey="Mueller, Stefan P" sort="Mueller, Stefan P" uniqKey="Mueller S" first="Stefan P." last="Müeller">Stefan P. Müeller</name><name sortKey="O Doherty, Michael J" sort="O Doherty, Michael J" uniqKey="O Doherty M" first="Michael J." last="O'Doherty">Michael J. O'Doherty</name><name sortKey="Schwartz, Lawrence H" sort="Schwartz, Lawrence H" uniqKey="Schwartz L" first="Lawrence H." last="Schwartz">Lawrence H. Schwartz</name><name sortKey="Trotman, Judith" sort="Trotman, Judith" uniqKey="Trotman J" first="Judith" last="Trotman">Judith Trotman</name><name sortKey="Zucca, Emanuele" sort="Zucca, Emanuele" uniqKey="Zucca E" first="Emanuele" last="Zucca">Emanuele Zucca</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003534 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003534 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:5015423
|texte= Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25113771" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |